Investigating the intervention of mindfulness on on promoting medication adherence among patient with epilepsy
Not Applicable
- Conditions
- Epilepsy.Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizuresG40.1
- Registration Number
- IRCT20181226042140N2
- Lead Sponsor
- ational Institute for Medical Research Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 256
Inclusion Criteria
A confirmed diagnosis of epilepsy in patients by a physician specializing in neurology
An age of 18 years or older
Prescribing antiepileptic drugs
Being responsible for taking the medicine by oneself or an independent person
Exclusion Criteria
Suffering from progressive neurological disease
Do not prescribed antiepileptic drugs
Diagnosis of an intellectual disability
Having a major cognitive impairment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The medication adherence score. Timepoint: Immediately after the intervention and 6 months after the intervention. Method of measurement: The Medication Adherence Report Scale(MARS).;Mindful Attention Awareness score. Timepoint: Immediately after the intervention and 6 months after the intervention. Method of measurement: Mindful Attention Awareness Scale(MAAS).
- Secondary Outcome Measures
Name Time Method